Platform

Antibody Pipeline

We build dynamic industry partnerships to co-develop and accelerate breakthrough antibody therapies that address critical global health challenges.

Pipeline of partnered mAbs therapeutics

Candidate Partner Indication Stage
04_A06
HIV Preclinical
007
HIV Preclinical

Molecules exclusively licensed to Vir Biotechnology for clinical development and commercialization.